What is the evidence grade for DSIP (Delta Sleep-Inducing Peptide)?

DSIP (Delta Sleep-Inducing Peptide) carries an evidence grade of Preliminary (score 2.5). Animal or in-vitro only

What is the risk band for DSIP (Delta Sleep-Inducing Peptide)?

DSIP (Delta Sleep-Inducing Peptide) is rated Moderate risk. Known AEs, monitoring advised

What is the regulatory status of DSIP (Delta Sleep-Inducing Peptide)?

DSIP (Delta Sleep-Inducing Peptide) has a status of Investigational based on Peptides Pub's classification of clinical stage and approval data.

What research goals is DSIP (Delta Sleep-Inducing Peptide) studied for?

DSIP (Delta Sleep-Inducing Peptide) is studied in relation to the following research goals: Cognition & mood.

PEP-0029Investigational

DSIP (Delta Sleep-Inducing Peptide)

Also known as

DSIP (Delta Sleep-Inducing Peptide) is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

Evidence

Preliminary· 2.5

Animal or in-vitro only

Risk band

Moderate

Known AEs, monitoring advised

Research goals

Cognition & mood

Summary

DSIP (delta sleep-inducing peptide) is a nonapeptide originally isolated for its association with sleep regulation. No usable study abstracts were provided in this dataset, so no specific efficacy, safety, or mechanistic claims can be substantiated here. The available signals indicate at most a single small registered clinical trial (around 40 participants) and no randomized controlled trials, meta-analyses, or FDA record. Evidence for DSIP as an administered therapeutic is therefore preliminary, and any claimed benefits should be regarded as unproven on the basis of the material supplied.

No indexed peer-reviewed sources for this entry yet.

For educational purposes only.

← Back to the encyclopedia